Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017129649) COMPOSITIONS WITH SPECIFIC OLIGOSACCHARIDES TO PREVENT LATER IN LIFE OBESITY OR RELATED COMORBIDITIES, BY INCREASING COLONIC SCFA PRODUCTION AND/OR BY INCREASING GLP-1 SECRETION
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/129649 International Application No.: PCT/EP2017/051592
Publication Date: 03.08.2017 International Filing Date: 26.01.2017
IPC:
A61K 31/702 (2006.01) ,A23L 33/00 (2016.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
702
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
[IPC code unknown for A23L 33]
Applicants:
NESTEC S.A. [CH/CH]; Avenue Nestlé 55 1800 Vevey, CH
Inventors:
BINIA, Aristea; CH
NEMBRINI, Chiara; CH
SPRENGER, Norbert; CH
AVANTI NIGRO, Ornella; CH
Agent:
FRAISSE, Sandrine; CH
Priority Data:
16152751.026.01.2016EP
Title (EN) COMPOSITIONS WITH SPECIFIC OLIGOSACCHARIDES TO PREVENT LATER IN LIFE OBESITY OR RELATED COMORBIDITIES, BY INCREASING COLONIC SCFA PRODUCTION AND/OR BY INCREASING GLP-1 SECRETION
(FR) COMPOSITIONS COMPORTANT DES OLIGOSACCHARIDES SPÉCIFIQUES POUR PRÉVENIR UNE OBÉSITÉ OU DES COMORDITÉS ASSOCIÉES SURVENANT PLUS TARD DANS LA VIE, PAR RENFORCEMENT DE LA PRODUCTION, PAR LE COLON, D'ACIDES GRAS À CHAÎNE COURTE ET/OU PAR RENFORCEMENT DE LA SÉCRÉTION DE GLP-1
Abstract:
(EN) The present invention relates to a nutritional composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising at least one N-acetylated oligosaccharide, one galacto-oligosaccharide and one sialylated oligosaccharide for use in reducing and/or avoiding excessive fat mass accumulation and/or in preventing anyrelated later in life health disordersin an infant or a young child such as later in life obesity and related comorbidities, by increasing colonic SCFA production and/or GLP-1 secretion/releasein said infant or young child.
(FR) La présente invention concerne une composition nutritionnelle comprenant un mélange d'oligosaccharides, ledit mélange d'oligosaccharides comprenant au moins un oligosaccharide N-acétylé, un galacto-oligosaccharide et un oligosaccharide sialylé pour utilisation dans la réduction et/ou la prévention, chez un nourrisson ou un enfant en bas âge, de l'accumulation excessive de masse adipeuse et/ou dans la prévention d'une quelconque affection associée survenant plus tard dans la vie, de type obésité et comorbidités associées survenant plus tard dans la vie, par renforcement de la production, par le côlon, d'acides gras à chaîne courte et/ou par renforcement de la sécrétion/libération de GLP-1 chez ledit nourrisson ou enfant en bas âge.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU2017211273CN108495637EP3407896PH1/2018/501299US20190046545